Recombinant CD22 (Pinatuzumab Biosimilar) antibody (PE)
The Humanized Monoclonal anti-CD22 (Pinatuzumab Biosimilar) antibody is suitable to detect CD22 (Pinatuzumab Biosimilar) in samples from Human. It has been validated for FACS.
Catalog No. ABIN7867143
$569.23
Plus shipping costs $50.00
100 tests
Shipping to:
United States
Delivery in 2 to 4 Business Days
Quick Overview for Recombinant CD22 (Pinatuzumab Biosimilar) antibody (PE) (ABIN7867143)
Target
CD22 (Pinatuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This CD22 (Pinatuzumab Biosimilar) antibody is conjugated to PE
Application
Flow Cytometry (FACS)
-
-
Purpose
- PE-conjugated Anti-CD22 (pinatuzumab biosimilar) mAb
-
Isotype
- IgG1
-
-
anti-CD22 (Pinatuzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2°C-8°C for 6 months
-
Expiry Date
- 6 months
-
-
- CD22 (Pinatuzumab Biosimilar)
-
Alternative Name
- pinatuzumab biosimilar
-
Target Type
- Biosimilar
-
Background
-
Synonyms: CD22,SIGLEC2,BL-CAM,SIGLEC-2,Siglec2,SIGLEC2FLJ22814,ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P20273
Target
-
You are here:
